UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 70

Sortiert nach

Correspondence

Deutsches Ärzteblatt international, 2023-09

Nachtkamp, Kathrin

2023

Link zum Volltext

Verfügbarkeit prüfen

Assessing the Prognosis of Patients with Myelodysplastic Syndromes (MDS)

Cancers, 2022-04, Vol.14 (8), p.1941

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)

Haematologica (Roma), 2011-10, Vol.96 (10), p.1433-1440

2011

Link zum Volltext

Verfügbarkeit prüfen

Comparison of cytomorphology and histomorphology in myelodysplastic syndromes

Frontiers in oncology, 2024-04, Vol.14, p.1359115-1359115

2024

Link zum Volltext

Verfügbarkeit prüfen

Improved survival in MDS patients receiving iron chelation therapy – A matched pair analysis of 188 patients from the Düsseldorf MDS registry

Leukemia research, 2012-08, Vol.36 (8), p.1067-1070

2012

Link zum Volltext

Verfügbarkeit prüfen

Influence of platelet count at diagnosis and during the course of disease on prognosis in MDS patients

Annals of hematology, 2021-10, Vol.100 (10), p.2575-2584

2021

Link zum Volltext

Verfügbarkeit prüfen

Sorafenib and azacitidine as salvage therapy for relapse of FLT3‐ITD mutated AML after allo‐SCT

European journal of haematology, 2017-04, Vol.98 (4), p.348-354

2017

Link zum Volltext

Verfügbarkeit prüfen

Relapse patterns and treatment strategies in patients receiving allogeneic hematopoietic stem cell transplantation for myeloid malignancies

Annals of hematology, 2019-05, Vol.98 (5), p.1225-1235

2019

Link zum Volltext

Verfügbarkeit prüfen

New proposals of the WHO working group (2016) for the diagnosis of myelodysplastic syndromes (MDS): Characteristics of refined MDS types

Leukemia research, 2017-06, Vol.57, p.78-84

2017

Link zum Volltext

Verfügbarkeit prüfen

Opportunities for Participation in Randomized Controlled Trials for Patients with Multiple Myeloma: Trial Access Depends on Restrictive Eligibility Criteria and Patient Expectations

Cancers, 2022-04, Vol.14 (9), p.2147

2022

Link zum Volltext

Verfügbarkeit prüfen

The Absolute Monocyte Count at Diagnosis Affects Prognosis in Myelodysplastic Syndromes Independently of the IPSS-R Risk Score

Cancers, 2023-07, Vol.15 (14), p.3572

2023

Link zum Volltext

Verfügbarkeit prüfen

In Reply

Deutsches Ärzteblatt international, 2023-09, Vol.120 (37), p.616-616

Nachtkamp, Kathrin

2023

Link zum Volltext

Verfügbarkeit prüfen

Smart Conditioning with Venetoclax-Enhanced Sequential FLAMSA + RIC in Patients with High-Risk Myeloid Malignancies

Cancers, 2024-01, Vol.16 (3), p.532

2024

Link zum Volltext

Verfügbarkeit prüfen

In Reply

Deutsches Ärzteblatt international, 2023-09, Vol.120 (37), p.616-616

Nachtkamp, Kathrin

2023

Link zum Volltext

Verfügbarkeit prüfen

The myelodysplastic syndrome-comorbidity index provides additional prognostic information on patients stratified according to the revised international prognostic scoring system

Haematologica (Roma), 2014-03, Vol.99 (3), p.e31

2014

Link zum Volltext

Verfügbarkeit prüfen

The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome

Haematologica (Roma), 2009-05, Vol.94 (5), p.729-732

2009

Link zum Volltext

Verfügbarkeit prüfen

P725: BATTLE OF THE GIANTS – COMPARISON OF IPSS‐M AND IPSS‐R IN PATIENTS WITH MISSING MOLECULAR DATA EXCEPT TP53 MUTATION STATUS FROM THE DÜSSELDORF MDS REGISTRY

HemaSphere, 2023-08, Vol.7 (S3), p.e788330c-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Cellularity, characteristics of hematopoietic parameters and prognosis in myelodysplastic syndromes

European journal of haematology, 2015-09, Vol.95 (3), p.181-189

2015

Link zum Volltext

Verfügbarkeit prüfen

Myelodysplastic syndromes: new methods of diagnosis, prognostication, and treatment

Deutsches Ärzteblatt international, 2023-03

2023

Link zum Volltext

Verfügbarkeit prüfen

Validation and proposals for a refinement of the WHO 2008 classification of myelodysplastic syndromes without excess of blasts

Leukemia research, 2013-01, Vol.37 (1), p.64-70

2013

Link zum Volltext

Verfügbarkeit prüfen

Wilms' Tumor 1 Gene Expression Using a Standardized European LeukemiaNet-Certified Assay Compared to Other Methods for Detection of Minimal Residual Disease in Myelodysplastic Syndrome and Acute Myelogenous Leukemia after Allogeneic Blood Stem Cell Transplantation

Biology of blood and marrow transplantation, 2018-11, Vol.24 (11), p.2337-2343

2018

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Cytomorphology and Histopathology in Myelodysplastic Syndromes (MDS)

Blood, 2022-11, Vol.140 (Supplement 1), p.12345-12346

2022

Link zum Volltext

Verfügbarkeit prüfen

Severe Anemia Is Associated with a Risk of Infection in Patients with Myelodysplastic Syndromes

Blood, 2021-11, Vol.138 (Supplement 1), p.4668-4668

2021

Link zum Volltext

Verfügbarkeit prüfen

Validation of a Novel Algorithm with a High Specificity in Ruling out MDS

Blood, 2022-11, Vol.140 (Supplement 1), p.9789-9790

2022

Link zum Volltext

Verfügbarkeit prüfen

Matched-Pair Analysis of 186 MDS Patients Receiving Iron Chelation Therapy or Transfusion Therapy Only

Blood, 2009-11, Vol.114 (22), p.1747-1747

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 70

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(69)

Publikationsform

Artikel
(70)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(31)
Science & Technology
(31)
Hematology
(25)
Humans
(20)
Myelodysplastic Syndromes
(19)
Prognosis
(18)
Male
(16)
Oncology
(16)
Female
(15)
Aged
(13)
Middle Aged
(13)
Adult
(11)
Aged, 80 And Over
(10)
Myelodysplastic Syndromes - Diagnosis
(10)
Myelodysplastic Syndromes - Mortality
(8)
Retrospective Studies
(8)
Transplantation
(8)
Patients
(7)
Hematology, Oncology And Palliative Medicine
(6)
Myelodysplastic Syndrome
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Correspondence

Assessing the Prognosis of Patients with Myelodysplastic Syndromes (MDS)

Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)

Comparison of cytomorphology and histomorphology in myelodysplastic syndromes

Improved survival in MDS patients receiving iron chelation therapy – A matched pair analysis of 188 patients from the Düsseldorf MDS registry

Influence of platelet count at diagnosis and during the course of disease on prognosis in MDS patients

Sorafenib and azacitidine as salvage therapy for relapse of FLT3‐ITD mutated AML after allo‐SCT

Relapse patterns and treatment strategies in patients receiving allogeneic hematopoietic stem cell transplantation for myeloid malignancies

New proposals of the WHO working group (2016) for the diagnosis of myelodysplastic syndromes (MDS): Characteristics of refined MDS types

Opportunities for Participation in Randomized Controlled Trials for Patients with Multiple Myeloma: Trial Access Depends on Restrictive Eligibility Criteria and Patient Expectations

The Absolute Monocyte Count at Diagnosis Affects Prognosis in Myelodysplastic Syndromes Independently of the IPSS-R Risk Score

In Reply

Smart Conditioning with Venetoclax-Enhanced Sequential FLAMSA + RIC in Patients with High-Risk Myeloid Malignancies

In Reply

The myelodysplastic syndrome-comorbidity index provides additional prognostic information on patients stratified according to the revised international prognostic scoring system

The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome

P725: BATTLE OF THE GIANTS – COMPARISON OF IPSS‐M AND IPSS‐R IN PATIENTS WITH MISSING MOLECULAR DATA EXCEPT TP53 MUTATION STATUS FROM THE DÜSSELDORF MDS REGISTRY

Cellularity, characteristics of hematopoietic parameters and prognosis in myelodysplastic syndromes

Myelodysplastic syndromes: new methods of diagnosis, prognostication, and treatment

Validation and proposals for a refinement of the WHO 2008 classification of myelodysplastic syndromes without excess of blasts

Wilms' Tumor 1 Gene Expression Using a Standardized European LeukemiaNet-Certified Assay Compared to Other Methods for Detection of Minimal Residual Disease in Myelodysplastic Syndrome and Acute Myelogenous Leukemia after Allogeneic Blood Stem Cell Transplantation

Comparison of Cytomorphology and Histopathology in Myelodysplastic Syndromes (MDS)

Severe Anemia Is Associated with a Risk of Infection in Patients with Myelodysplastic Syndromes

Validation of a Novel Algorithm with a High Specificity in Ruling out MDS

Matched-Pair Analysis of 186 MDS Patients Receiving Iron Chelation Therapy or Transfusion Therapy Only

Suchergebnisse filtern